Renier J. Brentjens – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:23:28 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Renier J. Brentjens – VJRegenMed https://mirror.vjregenmed.com 32 32 Innovative CAR designs https://mirror.vjregenmed.com/video/qgsagd9o8bu-innovative-car-designs/ Thu, 08 Oct 2020 14:08:16 +0000 http://13.40.107.223/video/qgsagd9o8bu-innovative-car-designs/ Renier J. Brentjens, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses novel CAR designs aimed to improve the efficacy of CAR T-cell recipients, including the development of armored CAR T-cells able to further penetrate malignancies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc)

]]>
Challenges in CAR T-cell therapy https://mirror.vjregenmed.com/video/kzcapt2n91g-challenges-in-car-t-cell-therapy/ Thu, 08 Oct 2020 14:08:16 +0000 http://13.40.107.223/video/kzcapt2n91g-challenges-in-car-t-cell-therapy/ Renier J. Brentjens, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, outlines the major challenges in CAR T-cell therapies including remission and relapse rate, cost, as well as targeting associated toxicities. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>